GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (STU:0NN) » Definitions » Net Margin %

Avicanna (STU:0NN) Net Margin % : -12.53% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Avicanna Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Avicanna's Net Income for the three months ended in Sep. 2024 was €-0.52 Mil. Avicanna's Revenue for the three months ended in Sep. 2024 was €4.17 Mil. Therefore, Avicanna's net margin for the quarter that ended in Sep. 2024 was -12.53%.

The historical rank and industry rank for Avicanna's Net Margin % or its related term are showing as below:

STU:0NN' s Net Margin % Range Over the Past 10 Years
Min: -13222.02   Med: -2093.12   Max: -27.31
Current: -27.31


STU:0NN's Net Margin % is ranked worse than
80.89% of 989 companies
in the Drug Manufacturers industry
Industry Median: 4.3 vs STU:0NN: -27.31

Avicanna Net Margin % Historical Data

The historical data trend for Avicanna's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Net Margin % Chart

Avicanna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -13,200.87 -2,092.16 -513.19 -363.99 -52.07

Avicanna Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.77 -50.40 -15.80 -31.75 -12.53

Competitive Comparison of Avicanna's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Avicanna's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avicanna's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avicanna's Net Margin % distribution charts can be found below:

* The bar in red indicates where Avicanna's Net Margin % falls into.



Avicanna Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Avicanna's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-5.976/11.477
=-52.07 %

Avicanna's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-0.523/4.173
=-12.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avicanna  (STU:0NN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Avicanna Net Margin % Related Terms

Thank you for viewing the detailed overview of Avicanna's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avicanna Business Description

Traded in Other Exchanges
Address
480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Avicanna Headlines

No Headlines